What is Opko Health's R&D?

Opko Health (OPK) reported R&D of $29.2M in Q1 2026.

How has Opko Health's R&D changed year-over-year?

Opko Health's R&D decreased by 5.3% year-over-year, from $30.84M to $29.2M.

What is the long-term trend for Opko Health's R&D?

Over 3 years (2021 to 2025), Opko Health's R&D has grown at a 17.3% compound annual growth rate (CAGR), from $76.85M to $124.03M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Opko Health OPK R&D

R&D at other companies

Olema Pharmaceuticals, Inc.OLMA

$49.23M+60.8%

HRO

HarrowHROW

$5.9M+94.8%

PrecigenPGEN

$5.64M-46.2%

ImmunomeIMNM

$46.38M+25.8%

Ultragenyx PharmaceuticalRARE

$187M+12.7%

AbbottABT

$767M+7.1%

Segments

By segment

See full

Pharmaceutical$28.75M-4.9%

Diagnostics$312K-42.0%

Other financials

Income statement

See full

Revenue$124.2M-17.2%

Gross profit$45.8M+7.4%

Operating income-$51.0M+24.0%

Net income-$54.8M+18.9%

EPS (diluted)-$0.07+30.0%

Balance sheet

See full

Cash & equivalents$40.6M-62.5%

Total debt$52.8M-4.2%

Total equity$1.2B-8.2%

Total assets$1.9B-12.8%

Cash flow

See full

Operating cash flow-$19.3M+44.1%

CapEx$1.8M-42.6%

Free cash flow-$21.1M+44.0%

Valuation

See full

Market cap$1.13B-22.4%

P/S1.9×-0.2×

Profitability

See full

Gross margin36%+4.2pp

Operating margin-17.4%-5.6pp

Net margin-36.6%-44.8pp

FCF margin-30%+0.1pp

Returns & leverage

See full

Return on equity-16.9%-21.7pp

Debt / equity0×0.0×

Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opko Health's R&D?: Opko Health (OPK) reported R&D of $29.2M in Q1 2026.
How has Opko Health's R&D changed year-over-year?: Opko Health's R&D decreased by 5.3% year-over-year, from $30.84M to $29.2M.
What is the long-term trend for Opko Health's R&D?: Over 3 years (2021 to 2025), Opko Health's R&D has grown at a 17.3% compound annual growth rate (CAGR), from $76.85M to $124.03M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.